BridgeMD
Compares treatment options for Breast Cancer
Official title Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx
ClinicalTrials.gov ID: NCT06426810
What this study is testing
- What it's testing
- The efficacy of electrosurgical bipolar systems in axillary lymph node dissection for breast cancer surgery is well known. In this study, the investigators aim to determine whether using electrosurgical bipolar systems helps reduce seroma formation in high-risk patients undergoing sentinel lymph node biopsy (SLNB) for breast cancer surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80, women only
You may be able to join if
- Women aged 20-80
- Candidates for breast-conserving surgery and axillary sentinel lymph node biopsy
- BMI over 25 or those who have received preoperative chemotherapy
- Overall performance status of Eastern Cooperative Oncology Group (ECOG) 0-2
- Participants who understand the study contents and can provide written consent
You likely can't join if
- Those with suspected axillary lymph node enlargement or metastasis on preoperative imaging (breast MRI, chest CT, breast ultrasound)
- Among patients who had confirmed lymph node metastasis before neoadjuvant chemotherapy, whose preopreative image showed residual disease at axillary...
- Those planning for mastectomy
- Those planning for axillary lymph node dissection without SLNBx
- Male breast cancer patients
- Patients with bilateral breast cancer
See the full eligibility criteria
- Women aged 20-80
- Candidates for breast-conserving surgery and axillary sentinel lymph node biopsy
- BMI over 25 or those who have received preoperative chemotherapy
- Overall performance status of Eastern Cooperative Oncology Group (ECOG) 0-2
- Participants who understand the study contents and can provide written consent
- Participants without evidence of distant metastasis
- Those with suspected axillary lymph node enlargement or metastasis on preoperative imaging (breast MRI, chest CT, breast ultrasound)
- Among patients who had confirmed lymph node metastasis before neoadjuvant chemotherapy, whose preopreative image showed residual disease at axillary lymph node
- Those planning for mastectomy
- Those planning for axillary lymph node dissection without SLNBx
- Male breast cancer patients
- Patients with bilateral breast cancer
- Illiterate individuals, foreigners, or others who cannot read or understand the consent form
- Individuals who voluntarily decide not to participate in the study or do not sign the consent form
- Those judged by the researcher to be inappropriate for participation in this study
- Study participants who did not have a drain inserted in the surgical area
- If the assigned by chance device is not used due to surgical room conditions (e.g., unavailability due to other emergency surgeries, device malfunction) and another device is substituted
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Dongjak-gu, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Dongjak-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.